| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_375ac29eab9f6a116ad2a6de7ad66349
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5730065ea70049a3078fa095503d0cfe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0400d5b0eb223403ad9e1fc49ee7466
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18379196826ecfd816c70811e217d126
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c53b417697c047b945851a846059c5b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61531bb60b63d2f7c50acce789ce8d46 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4188
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y603-04015 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4188 |
| filingDate |
2022-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2022-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-202022104906-U1 |
| titleOfInvention |
Formulation to prevent pathogenic E. coli infection |
| abstract |
A formulation for preventing pathogenic E. coli infection, the formulation comprising:a biotin;a biotin protein ligase BirA, which serves as an enzyme that metabolizes the biotin; anda negative transcription regulator of the biotin synthesis operon (bio operon) containing bioA and bioBFCD regulates biotin synthesis in E. coli depending on biotin supply and demand,wherein BirA in combination with biotin directly binds to the 40 bp biotin operon ( bioO) binds to repress transcription of the bio operon when biotin levels are too high for bacterial physiology. |
| priorityDate |
2022-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |